Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype

GLIA

Volumn 61, Issue 3, 2013, Pages 409-419

  Roberts, Kate ^a   Zeineddine, Rafaa ^a   Corcoran, Lisa ^a   Li, Wen ^b   Campbell, Iain L ^b   Yerbury, Justin J ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Amyotrophic lateral sclerosis; Microglia; Protein aggregation; SOD1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; LIPID RAFT; MICROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL LINE; CELL SURVIVAL; GLIOSIS; MEMBRANE MICRODOMAINS; MICE; MICROGLIA; MOTOR NEURONS; SUPEROXIDE DISMUTASE;

EID: 84872611309     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22444     Document Type: Article

References (57)

1. Alexianu ME, Kozovska M, Appel SH. 2001. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57: 1282-1289.
2. Bal-Price A, Brown GC. 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21: 6480-6491.
3. Bamberger ME, Harris ME, McDonald DR, Husemann J, Landreth GE. 2003. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci 23: 2665-2674.
4. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103: 16021-16026.
5. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392.
6. Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, Frosch MP, Agar JN, Julien JP, Brady ST, Brown RHJr. 2010. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13: 1396-1403.
7. Carter SL, Muller M, Manders PM, Campbell IL. 2007. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55: 1728-1739.
8. Casal C, Serratosa J, Tusell JM. 2002. Relationship between beta-AP peptide aggregation and microglial activation. Brain Res 928: 76-84.
9. Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, Whitelegge JP, Valentine JS. 2008. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci USA 105: 18663-18668.
10. Cimini V, Ruggiero G, Buonomo T, Seru R, Sciorio S, Zanzi C, Santangelo F, Mondola P. 2002. CuZn-superoxide dismutase in human thymus: Immunocytochemical localisation and secretion in thymus-derived epithelial and fibroblast cell lines. Histochem Cell Biol 118: 163-169.
11. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, Brown RHJr, Julien JP, Goldstein LS, Cleveland DW. 2003. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302: 113-117.
12. Coraci IS, Husemann J, Berman JW, Hulette C, Dufour JH, Campanella GK, Luster AD, Silverstein SC, El-Khoury JB. 2002. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol 160: 101-112.
13. Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, Ajroud K, Mishra M, Ajroud-Driss S, Heller S, Sufit R, Siddique N, Mugnaini E, Siddique T. 2010. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67: 739-748.
14. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. 1996. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382: 716-719.
15. Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, Jacobsson J, Rosquist R, Marklund SL, Brannstrom T. 2010. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PloS one 5: e11552.
16. Fu H, Liu B, Frost JL, Hong S, Jin M, Ostaszewski B, Shankar GM, Costantino IM, Carroll MC, Mayadas TN, Lemere CA. 2012. Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Abeta by microglia. Glia 60: 993-1003.
17. Fushimi K, Long C, Jayaram N, Chen X, Li L, Wu JY. 2011. Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell 2: 141-149.
18. Gomes C, Keller S, Altevogt P, Costa J. 2007. Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett 428: 43-46.
19. Gowen BB, Borg TK, Ghaffar A, Mayer EP. 2001. The collagenous domain of class A scavenger receptors is involved in macrophage adhesion to collagens. J Leukocyte Biol 69: 575-582.
20. Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, Rao EJ, Yang M, Ye H, Zhu L, Liu J, Xu M, Yang Y, Wang C, Zhang D, Bigio EH, Mesulam M, Shen Y, Xu Q, Fushimi K, Wu JY. 2011. An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol 18: 822-830.
21. Hall ED, Oostveen JA, Gurney ME. 1998. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23: 249-256.
22. Henkel JS, Beers DR, Siklos L, Appel SH. 2006. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci 31: 427-437.
23. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, Beutler B. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523-527.
24. Horiuchi S, Sakamoto Y, Sakai M. 2003. Scavenger receptors for oxidized and glycated proteins. Amino acids 25: 283-292.
25. Hossaini M, Cano SC, van Dis V, Haasdijk ED, Hoogenraad CC, Holstege JC, Jaarsma D. 2011. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice. J Neuropathol Exper Neurol 70: 662-677.
26. Jacobsson J, Jonsson PA, Andersen PM, Forsgren L, Marklund SL. 2001. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations. Brain: J Neurol 124(Pt 7): 1461-1466.
27. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. 2009. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284: 20329-20339.
28. Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ. 2008. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11: 1294-1301.
29. Lindberg MJ, Tibell L, Oliveberg M. 2002. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: Decreased stability of the apo state. Proc Natl Acad Sci USA 99: 16607-16612.
30. Maezawa I, Zimin PI, Wulff H, Jin LW. 2011. Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J Biol Chem 286: 3693-3706.
31. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, Komure O, Matsuura S, Kobatake K, Morimoto N, Abe K, Suzuki N, Aoki M, Kawata A, Hirai T, Kato T, Ogasawara K, Hirano A, Takumi T, Kusaka H, Hagiwara K, Kaji R, Kawakami H. 2010. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465: 223-226.
32. Matsumoto G, Stojanovic A, Holmberg CI, Kim S, Morimoto RI. 2005. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol 171: 75-85.
33. Miller DW, Cookson MR, Dickson DW. 2004. Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol 1: 13-21.
34. Mondola P, Annella T, Santillo M, Santangelo F. 1996. Evidence for secretion of cytosolic CuZn superoxide dismutase by Hep G2 cells and human fibroblasts. Int J Biochem Cell Biol 28: 677-681.
35. Mondola P, Annella T, Seru R, Santangelo F, Iossa S, Gioielli A, Santillo M. 1998. Secretion and increase of intracellular CuZn superoxide dismutase content in human neuroblastoma SK-N-BE cells subjected to oxidative stress. Brain Research Bull 45: 517-520.
36. Mondola P, Bifulco M, Seru R, Annella T, Ciriolo MR, Santillo M. 2000. Presence of CuZn superoxide dismutase in human serum lipoproteins. FEBS Lett 467: 57-60.
37. Munch C, O'Brien J, Bertolotti A. 2011. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci USA 108: 3548-3553.
38. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
39. Pasinelli P, Brown RH. 2006. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat Rev Neurosci 7: 710-723.
40. Pramatarova A, Laganiere J, Roussel J, Brisebois K, Rouleau GA. 2001. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21: 3369-3374.
41. Reed-Geaghan EG, Savage JC, Hise AG, Landreth GE. 2009. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J Neurosci 29: 11982-11992.
42. Rossi D, Brambilla L, Valori CF, Roncoroni C, Crugnola A, Yokota T, Bredesen DE, Volterra A. 2008. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ 15: 1691-1700.
43. Santillo M, Secondo A, Seru R, Damiano S, Garbi C, Taverna E, Rosa P, Giovedi S, Benfenati F, Mondola P. 2007. Evidence of calcium- and SNARE-dependent release of CuZn superoxide dismutase from rat pituitary GH3 cells and synaptosomes in response to depolarization. J Neurochem 102: 679-685.
44. Soo KY, Atkin JD, Horne MK, Nagley P. 2009. Recruitment of mitochondria into apoptotic signaling correlates with the presence of inclusions formed by amyotrophic lateral sclerosis-associated SOD1 mutations. J Neurochem 108: 578-590.
45. Stevens JC, Chia R, Hendriks WT, Bros-Facer V, van Minnen J, Martin JE, Jackson GS, Greensmith L, Schiavo G, Fisher EM. 2010. Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag-Implications for research into amyotrophic lateral sclerosis (ALS). PloS one 5: e9541.
46. Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, Lopes EC, Patch JD, Hill AF, Cheema SS. 2005. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci 25: 108-117.
47. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB. 2004. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15: 601-609.
48. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. 2006. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9: 108-118.
49. Walker WS, Gatewood J, Olivas E, Askew D, Havenith CE. 1995. Mouse microglial cell lines differing in constitutive and interferon-gamma-inducible antigen-presenting activities for naive and memory CD4+ and CD8+ T cells. J Neuroimmunol 63: 163-174.
50. Wang Q, Johnson JL, Agar NY, Agar JN. 2008. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol 6: e170.
51. Wang J, Xu G, Borchelt DR. 2002. High molecular weight complexes of mutant superoxide dismutase 1: Age-dependent and tissue-specific accumulation. Neurobiol Dis 9: 139-148.
52. Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD. 2001. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiology Dis 8: 933-941.
53. Wyatt AR, Yerbury JJ, Berghofer P, Greguric I, Katsifis A, Dobson CM, Wilson MR. 2011. Clusterin facilitates in vivo clearance of extracellular misfolded proteins. Cell Mol Life Sci: CMLS 68: 3919-3931.
54. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
55. Zeng Y, Tao N, Chung KN, Heuser JE, Lublin DM. 2003. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J Biol Chem 278: 45931-45936.
56. Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhou Y, Hong JS, Zhang J. 2005. Aggregated alpha-synuclein activates microglia: A process leading to disease progression in Parkinson's disease. FASEB J 19: 533-542.
57. Zhao W, Beers DR, Henkel JS, Zhang W, Urushitani M, Julien JP, Appel SH. 2010. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58: 231-243.